Bevacizumab/PD-1 inhibitor plus chemotherapy as first-line treatment of advanced non-squamous non-small-cell lung cancer

• Main Authors: Jing Wang (Author), Qin Chen (Author), Xinyue Wang (Author), Dingzhi Huang (Author), Richeng Jiang (Author)
• Format: Knjiga
• Izdano: Becaris Publishing Limited, 2023-04-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Aim: To compare the effectiveness of PD-1 inhibitor or bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (nsNSCLC). Methods: We retrospectively collected data for patients with advanced nsNSCLC who underwent first-line treatment with PD-1 inhibitor or bevacizumab plus...